Law360, New York (January 09, 2012, 2:08 PM ET) -- Novartis Consumer Health Inc. recalled several popular over-the-counter drugs and suspended operations at a Nebraska facility Sunday following consumer complaints about damaged pills, inconsistent packaging and mixed tablets, taking a $120 million charge to do so.
The drugmaker said it was voluntarily pulling certain lots of Excedrin, NoDoz, Bufferin and Gas-X Prevention over concerns that they may contain broken or chipped pills, or stray tablets or capsules from different Novartis products.
An estimated $120 million charge in the fourth quarter of 2011 will cover the recall...
Novartis Issues $120M Drug Recall, Plant Suspension
To view the full article, take a free trial now.
